Get the Stockscreener App
421.11
9.96%
38.14
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Chemed Corp stock is traded at $421.11, with a volume of 606.84K.
It is up +9.96% in the last 24 hours and up +12.63% over the past month.
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
See More
Previous Close:
$382.97
Open:
$444.5
24h Volume:
606.84K
Relative Volume:
2.48
Market Cap:
$5.65B
Revenue:
$2.54B
Net Income/Loss:
$259.78M
P/E Ratio:
22.95
EPS:
18.3466
Net Cash Flow:
$377.12M
1W Performance:
+9.49%
1M Performance:
+12.63%
6M Performance:
-3.55%
1Y Performance:
-22.98%
1-Day Range:
$415.34
$453.61
1-Week Range:
$371.00
$453.61
52-Week Range:
$365.20
$583.96
Chemed Corp Stock (CHE) Company Profile
Name
Chemed Corp
Sector
Industry
Phone
(513)762-6690
Address
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
421.11 | 5.65B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
432.46 | 96.68B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
180.81 | 15.84B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.77 | 12.44B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
189.16 | 11.05B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
174.35 | 10.64B | 17.36B | 1.51B | 849.25M | 23.15 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Sep-02-25 | Upgrade | Jefferies | Hold → Buy |
| Jul-25-25 | Initiated | Jefferies | Hold |
| Mar-11-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-19 | Upgrade | JMP Securities | Mkt Perform → Mkt Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Buy |
| Oct-12-18 | Initiated | BofA/Merrill | Buy |
| Aug-28-17 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Jul-27-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-02-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-26-15 | Reiterated | Oppenheimer | Outperform |
| Oct-26-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-22-15 | Reiterated | Oppenheimer | Outperform |
| Jul-27-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Feb-19-15 | Reiterated | Oppenheimer | Outperform |
| Sep-23-14 | Reiterated | Oppenheimer | Outperform |
| Jun-10-14 | Reiterated | RBC Capital Mkts | Sector Perform |
| May-01-14 | Reiterated | Oppenheimer | Outperform |
| Sep-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-04-11 | Reiterated | Barclays Capital | Underweight |
| Feb-17-11 | Reiterated | Oppenheimer | Outperform |
| Feb-17-11 | Reiterated | RBC Capital Mkts | Sector Perform |
View All
Chemed Corp Stock (CHE) Latest News
CHE Q1 Deep Dive: VITAS Drives Growth, Roto-Rooter Adapts to Higher Marketing Costs - Yahoo! Finance Canada
Impax Asset Management Group plc Trims Position in Chemed Corporation $CHE - MarketBeat
Chemed Corporation (NYSE:CHE) Q1 2026 Earnings Call Transcript - Insider Monkey
Chemed Stock Jumps 11% on Q1 Beat, VITAS Hospice Strength and Raised 2026 Outlook - inkl
CHE: VITAS outperformed in Q1 2026, driving raised guidance, while Roto-Rooter navigated headwinds - TradingView
Full Transcript: Chemed Q1 2026 Earnings Call - Benzinga
CHE: VITAS outperformed expectations and guidance was raised, while Roto-Rooter saw mixed results and higher costs - TradingView
Chemed Q1 2026 presentation reveals Roto-Rooter divestiture plans - Investing.com
Transcript : Chemed Corporation, Q1 2026 Earnings Call, Apr 24, 2026 - marketscreener.com
Earnings call transcript: Chemed Q1 2026 earnings exceed forecasts, stock surges - Investing.com Canada
Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday - Benzinga
Chemed (NYSE:CHE) Shares Gap Up After Strong Earnings - MarketBeat
Copeland Capital Management LLC Sells 8,815 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Sold by State of Alaska Department of Revenue - MarketBeat
Chemed: Q1 Earnings Snapshot - theheraldreview.com
CHE: 2025 revenue grew 4.1% to $2.53B, but adjusted EBITDA and net income declined - TradingView
Chemed (NYSE:CHE) Posts Earnings Results, Beats Estimates By $0.35 EPS - MarketBeat
Chemed Corp (NYSE:CHE) Soars on Q1 Beat and Raised Full-Year Guidance - ChartMill
Chemed (NYSE:CHE) Issues FY 2026 Earnings Guidance - MarketBeat
CHE: VITAS outperformed, boosting guidance, while Roto-Rooter faced margin pressure and revenue decline - TradingView
Chemed Corp (CHE) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Chemed reports Q1 2026: Revenue $657.5M, GAAP EPS $4.84, Adjusted EPS $5.65 - TradingView
Chemed (NYSE: CHE) raises 2026 EPS guidance as VITAS outperforms, Roto-Rooter margins ease - Stock Titan
Chemed Reports First-Quarter 2026 Results - Bluefield Daily Telegraph
Chemed earnings on deck as hospice, plumbing units face tests - Investing.com UK
M&T Bank Corp Raises Stock Holdings in Chemed Corporation $CHE - MarketBeat
Chemed Corp. Q1 2026 Earnings Report: Forecast & Analyst SentimentNews and Statistics - IndexBox
CHE (Chemed Corp) reports Q4 2025 EPS miss and 4.1 percent year over year revenue growth, stock edges higher.EBITDA Margin - Cổng thông tin điện tử Tỉnh Sơn La
Evergreen Capital Management LLC Trims Position in Chemed Corporation $CHE - MarketBeat
Chemed Corporation $CHE Shares Sold by Boston Trust Walden Corp - MarketBeat
Chemed Corporation (NYSE:CHE) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
What could accelerate Chemed (CHE) stock growth (At Lows) 2026-04-20Price Momentum - UBND thành phố Hải Phòng
Chemed Corp (CHE) Stock Analysis: Evaluating a 15% Growth Potential Amidst Stable Healthcare Services - DirectorsTalk Interviews
Chemed Corp stock (US1638321034): Why Google Discover changes matter more now - AD HOC NEWS
Chemed Corp stock (US1638321034): Why does its hospice dominance matter more for U.S. investors now? - AD HOC NEWS
Responsive Playbooks and the CHE Inflection - Stock Traders Daily
Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
Chemed Corporation $CHE Shares Sold by Tudor Investment Corp ET AL - MarketBeat
Chemed (CHE) to Release Earnings on Thursday - MarketBeat
Chemed (CHE) Stock: Risk Exposure (Slow Grind) 2026-04-15Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh
CHE Stock Price, Quote & Chart | CHEMED CORP (NYSE:CHE) - ChartMill
Chemed secures $450 million revolving credit facility By Investing.com - Investing.com Canada
Chemed Renews $450 Million Five-Year Revolving Credit Facility Led by JPMorgan - TradingView
Chemed (NYSE: CHE) secures five-year $450M revolving credit facility - Stock Titan
Chemed secures $450 million revolving credit facility - Investing.com
Chemed Corporation Announces a Five-Year $450 Million Amended and Restated Credit Agreement - Yahoo Finance
CHE SEC FilingsChemed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Smith Salley Wealth Management's Chemed Corp(CHE) Holding History - GuruFocus
Oak Thistle LLC Sells 4,113 Shares of Chemed Corporation $CHE - MarketBeat
Clerical correction: Chemed (NYSE: CHE) restates shares outstanding for 2026 meeting - Stock Titan
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corp Stock (CHE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):